DK0592478T3 - Anvendelse af lipaser til fremstilling af lægemidler - Google Patents

Anvendelse af lipaser til fremstilling af lægemidler

Info

Publication number
DK0592478T3
DK0592478T3 DK92912628T DK92912628T DK0592478T3 DK 0592478 T3 DK0592478 T3 DK 0592478T3 DK 92912628 T DK92912628 T DK 92912628T DK 92912628 T DK92912628 T DK 92912628T DK 0592478 T3 DK0592478 T3 DK 0592478T3
Authority
DK
Denmark
Prior art keywords
pct
lipases
drugs
sec
manufacture
Prior art date
Application number
DK92912628T
Other languages
English (en)
Inventor
Reinhard Braatz
Roland Kurth
Elke Menkel-Conen
Hansjoerg Rettenmaier
Thomas Friedrich
Thomas Subkowski
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK0592478T3 publication Critical patent/DK0592478T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918—Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK92912628T 1991-07-01 1992-06-23 Anvendelse af lipaser til fremstilling af lægemidler DK0592478T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4121704 1991-07-01
PCT/EP1992/001412 WO1993000924A1 (de) 1991-07-01 1992-06-23 Verwendung von lipasen zur herstellung von arzneimitteln

Publications (1)

Publication Number Publication Date
DK0592478T3 true DK0592478T3 (da) 1999-08-30

Family

ID=6435147

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92912628T DK0592478T3 (da) 1991-07-01 1992-06-23 Anvendelse af lipaser til fremstilling af lægemidler

Country Status (10)

Country Link
US (3) US5489530A (da)
EP (1) EP0592478B1 (da)
JP (1) JP3593550B2 (da)
AT (1) ATE175117T1 (da)
CA (1) CA2110497C (da)
DE (1) DE59209604D1 (da)
DK (1) DK0592478T3 (da)
ES (1) ES2125901T3 (da)
MX (1) MX9203832A (da)
WO (1) WO1993000924A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
DE10032058A1 (de) * 2000-07-05 2002-01-17 Basf Ag Mikrobielle Produktion von R-Phenylacetylcarbinol durch biologische Umwandlung von Benzaldehyd durch filamentöse Pilze
CA2427537A1 (en) * 2000-11-02 2002-05-10 Cilian Ag Use of enzymes obtained from ciliates as medicaments for promoting digestion
AU785249B2 (en) * 2002-04-24 2006-12-07 Asahi Industrial Co., Ltd. New microorganism and drainage method
US7172895B2 (en) * 2002-04-25 2007-02-06 Takuya Kitamura Microorganism and drainage method
US7142464B2 (en) * 2003-04-29 2006-11-28 Saifun Semiconductors Ltd. Apparatus and methods for multi-level sensing in a memory array
RU2381813C2 (ru) * 2004-03-22 2010-02-20 Зольвай Фармасьютиклз Гмбх Пероральные фармацевтические композиции на основе продуктов, содержащих липазы, прежде всего панкреатин, и пав
BRPI0516515B1 (pt) * 2004-10-14 2018-05-29 Eli Lilly And Company Composição compreendendo lipase, protease e amilase e uso da mesma
BRPI0614914A2 (pt) * 2005-07-29 2011-04-19 Solvay Pharm Gmbh processos para a fabricação de pó de pancreatina esterilizada
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
PT2391382E (pt) 2009-01-29 2014-08-22 Nordmark Arzneimittel Gmbh & Co Kg Preparado farmacêutico contendo lipase de origem bacteriana
DE102009006594A1 (de) 2009-01-29 2010-08-05 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutisches Präparat
CN106139132A (zh) * 2009-01-29 2016-11-23 诺尔玛克药物有限责任及股份两合公司 细菌脂肪酶药物制剂
JP2014193909A (ja) * 2014-06-04 2014-10-09 Nordmark Arzneimittel Gmbh & Co Kg 医薬調製物
US20180028454A1 (en) 2015-02-04 2018-02-01 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
DE102015114857A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung
DE102015114859A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Verwendung einer pharmazeutischen Zusammensetzung, enthaltend mindestens ein Verdauungsenzym, bei der künstlichen Ernährung
DE102015114862A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung, enthaltend eine bakterielle Lipase
WO2017142904A1 (en) 2016-02-19 2017-08-24 Basf Se Baking lipases
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
DE102017104480A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Wässrige Lösung von Burlulipase umfassend Kalziumionen
CN110621162B (zh) 2017-05-12 2024-05-24 巴斯夫欧洲公司 脂肪酶
EP3701019A2 (en) 2017-10-25 2020-09-02 Basf Se Beta-amylase enzymes
WO2020185737A1 (en) 2019-03-11 2020-09-17 Basf Se Amylases and methods for making and using them

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1084431A (en) * 1964-05-06 1967-09-20 Analyses Et De Rech S Biolog M Improvements in and relating to lipases
US3431175A (en) * 1964-07-18 1969-03-04 Amano Pharma Co Ltd Method for the preparation of a lipoprotein lipase by cultivating organisms
DE1300487B (de) * 1965-08-19 1969-08-07 Hoechst Ag Verfahren zur mikrobiologischen Herstellung von Lipase
DE1642654C3 (de) * 1968-01-16 1979-11-29 Centre Europeen De Recherches Mauvernay, C.E.R.M., Riom Verfahren zur mikrobiologischen Herstellung eines stabilen gereinigten Lipase-Präparates und pharmazeutisches Mittel, welches dieses enthält
JPS4629787B1 (da) * 1968-07-02 1971-08-30
US3875007A (en) * 1972-11-03 1975-04-01 Amano Pharma Co Ltd Lipid metabolism improving and anti-atheromatic agent
US4019959A (en) * 1975-10-06 1977-04-26 Continental Oil Company Bacterial production of lipase and pyocyanine from n-paraffins
US4283494A (en) * 1978-04-26 1981-08-11 Meito Sangyo Kabushiki Kaisha Microbial lipase, process for its preparation and microbiologically pure culture therefor
GB8514708D0 (en) * 1985-06-11 1985-07-10 Unilever Plc Enzymatic detergent composition
EP0318775B1 (en) * 1987-12-03 1994-02-02 Chisso Corporation A lipase gene
JP3079276B2 (ja) * 1988-02-28 2000-08-21 天野製薬株式会社 組換え体ｄｎａ、それを含むシュードモナス属菌及びそれを用いたリパーゼの製造法
DE69004301T2 (de) * 1989-03-08 1994-03-24 Simon Lodewijk Scharpe Mischung zur Behandlung der von exokrinen Insuffizienz der Bauchspeicheldrüse und die Verwendung der genannten Mischung.

Also Published As

Publication number Publication date
US6030798A (en) 2000-02-29
ATE175117T1 (de) 1999-01-15
CA2110497C (en) 2005-04-19
EP0592478B1 (de) 1998-12-30
ES2125901T3 (es) 1999-03-16
WO1993000924A1 (de) 1993-01-21
US5645832A (en) 1997-07-08
US5489530A (en) 1996-02-06
JP3593550B2 (ja) 2004-11-24
MX9203832A (es) 1993-01-01
DE59209604D1 (de) 1999-02-11
EP0592478A1 (de) 1994-04-20
CA2110497A1 (en) 1993-01-21
JPH06509330A (ja) 1994-10-20

Similar Documents

Publication Publication Date Title
DK0592478T3 (da) Anvendelse af lipaser til fremstilling af lægemidler
ATE243735T1 (de) Alkalische lipase
KR850008282A (ko) 그람음성균상의 혈청형 리포다당류 결정인자에 대한 인체 단크론(monoclonal)항체와 그 제조방법
EP1050540A3 (en) Inhibitors of dipeptidyl-aminopeptidase type IV
DK0711360T3 (da) Fremgangsmåde til identificering af mikroorganismer under anvendelse af mindst to kromogener
AU4069297A (en) Methods of treating pulmonary diseases mediated by polyunsaturated lipid metabolites and assays for epoxide hydrolase inhibitors
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
AU7876491A (en) Pharmaceutical composition
UA50708C2 (uk) Моноклональне антитіло, яке має здатність розпізнавати антиген, який викликає апоптоз мієлоїдних клітин, фрагмент f(ab)2 моноклонального антитіла, гібридома ferm bp-4382
NO921876L (no) Enzymatisk spaltning av endo-bicyklo(2,2.1)heptan-2-ol ogavledede farmasoeytisk midler
ES2035260T3 (es) Cepa de microorganismos con actividad antimicrobiana.
AU571495B2 (en) Mucoid exopolysaccharide vaccine against pseudomonas aeruginosa
AU3580800A (en) Method of and compositions for immunization with the (pseudomonas) v antigen
ATE63338T1 (de) Verfahren zur herstellung von 6hydroxynikotins|ure.
MY129859A (en) Bacterial strains of the bacterium bacillus thuringiensis and uses therefor
NO307377B1 (no) Pyridyltioforbindelser for bekjempelse av Helicobacter- bakterier
DE3881531D1 (de) Verwendung von gamma-glutamyl-transpeptidase.
NO180642C (no) Alkalipullulanase og renisolert kultur av Bacillus sp. mikroorganisme som produserer denne
FI961054A (fi) Menetelmä 9-(2-hydroksi)etoksimetyyliguaniinin valmistamiseksi
ES8707114A1 (es) Procedimiento para la obtencion de un anticuerpo monoclonal anti-alfa-amilasa
AU1539695A (en) Bacterial strains of genus (bacillus) closely phenotypically related to genus (lactobacillus), culture method and use
FI944563A (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
DK148361C (da) Fremgangsmaade til fremstilling af kolesterinesterase
EP0071446A3 (en) Construction of microorganisms
ES8205017A1 (es) Procedimiento para la preparacion de carbamilderivados de &-hidroxiacidos.